Evidence map›Paper›PMID 25737130›Full record

ArticleScientific reports2015

Indirect protein quantification of drug-transforming enzymes using peptide group-specific immunoaffinity enrichment and mass spectrometry.

Frederik Weiß, Anke Schnabel, Hannes Planatscher, Bart H J van den Berg, Bettina Serschnitzki, Andreas K Nuessler, Wolfgang E Thasler, Thomas S Weiss, Matthias Reuss, Dieter Stoll and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 1 country.

Frederik WeißNMI Natural and Medical Sciences Institute at the University of Tübingen, Markwiesenstr. 55, Reutlingen, Germany.
Anke SchnabelMedizinisches Proteom-Center, Ruhr-University Bochum, Bochum, Germany.
Hannes PlanatscherNMI Natural and Medical Sciences Institute at the University of Tübingen, Markwiesenstr. 55, Reutlingen, Germany.
Bart H J van den BergNMI Natural and Medical Sciences Institute at the University of Tübingen, Markwiesenstr. 55, Reutlingen, Germany.
Bettina SerschnitzkiMedizinisches Proteom-Center, Ruhr-University Bochum, Bochum, Germany.
Andreas K NuesslerDepartment of Traumatology, Eberhard Karls Universität Tübingen, Tuebingen, Germany.
Wolfgang E ThaslerDepartment of Surgery, Ludwig-Maximilians-University, Munich, Germany.
Thomas S WeissDepartment of Pediatrics and Juvenile Medicine, Regensburg University Hospital, Regensburg, Germany.
Matthias ReussCenter Systems Biology, University of Stuttgart, Stuttgart, Germany.
Dieter StollUniversity of Applied Sciences, Albstadt Sigmaringen, Germany.
Markus F TemplinNMI Natural and Medical Sciences Institute at the University of Tübingen, Markwiesenstr. 55, Reutlingen, Germany.
Thomas O JoosNMI Natural and Medical Sciences Institute at the University of Tübingen, Markwiesenstr. 55, Reutlingen, Germany.
Katrin MarcusMedizinisches Proteom-Center, Ruhr-University Bochum, Bochum, Germany.
Oliver PoetzNMI Natural and Medical Sciences Institute at the University of Tübingen, Markwiesenstr. 55, Reutlingen, Germany.
Natural and Medical Sciences Institute · DERuhr University Bochum · DEAlbstadt-Sigmaringen University · DELudwig-Maximilians-Universität München · DEUniversity Hospital Regensburg · DEUniversity of Stuttgart · DEUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunoaffinity enrichment of proteotypic peptides, coupled with selected reaction monitoring, enables indirect protein quantification. However the lack of suitable antibodies limits its widespread application. We developed a method in which multi-specific antibodies are used to enrich groups of peptides, thus facilitating multiplexed quantitative protein assays. We tested this strategy in a pharmacokinetic experiment by targeting a group of homologous drug transforming proteins in human hepatocytes. Our results indicate the generic applicability of this method to any biological system.

Indexed as

Amino Acid SequenceAntibodiesAntibody AffinityAryl Hydrocarbon HydroxylasesAtorvastatinATP Binding Cassette Transporter, Subfamily BCells, CulturedChromatography, LiquidCytochrome P-450 CYP3AEpitopesHepatocytesHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMass SpectrometryPeptidesPravastatinABCB1 protein, humanAntibodiesAryl Hydrocarbon HydroxylasesAtorvastatinATP Binding Cassette Transporter, Subfamily BCYP3A7 protein, humanCytochrome P-450 CYP3AEpitopesHydroxymethylglutaryl-CoA Reductase InhibitorsPeptidesPravastatin

Identifiers

PMID25737130
PMCPMC4348618
OpenAlexW2090314515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.